-
公开(公告)号:US08747849B2
公开(公告)日:2014-06-10
申请号:US13051497
申请日:2011-03-18
申请人: Christopher Scott , Roberta Burden , Shane Olwill , Brian Walker , Jim Johnston
发明人: Christopher Scott , Roberta Burden , Shane Olwill , Brian Walker , Jim Johnston
IPC分类号: A61K39/395
CPC分类号: C07K16/40 , A61K2039/505 , C07K2317/56 , C07K2317/76 , C07K2317/92
摘要: Described are specific binding members e.g. antibodies which may be used in the treatment of diseases associated with cathepsin S activity. The specific binding members bind cathepsin S and inhibit its proteolytic activity. The binding members may be used in the treatment of diseases such as cancer, inflammatory diseases, neurodegenerative disorders, autoimmune disorders, and other diseases associated with excessive, deregulated or inappropriate angiogenesis.
摘要翻译: 描述的是具体的结合成员,例如 可用于治疗与组织蛋白酶S活性相关的疾病的抗体。 特异性结合成员结合组织蛋白酶S并抑制其蛋白水解活性。 结合成员可用于治疗诸如癌症,炎性疾病,神经变性疾病,自身免疫性疾病以及与过度,失调或不合适的血管生成相关的其它疾病的疾病。
-
公开(公告)号:US20110150886A1
公开(公告)日:2011-06-23
申请号:US12988135
申请日:2009-04-17
申请人: Jill Caswell , Shane Olwill , James Johnston , Richard Buick , Thomas Jaquin , Declan Doherty , Christopher Scott
发明人: Jill Caswell , Shane Olwill , James Johnston , Richard Buick , Thomas Jaquin , Declan Doherty , Christopher Scott
IPC分类号: A61K39/395 , A61K31/7088 , A61P35/00 , C07K16/18 , C07H21/04
CPC分类号: C07K16/22 , A61K39/39558 , A61K2039/505 , C07K16/2863 , C07K2317/31 , C07K2317/33 , C07K2317/73 , C07K2317/74 , A61K2300/00
摘要: Described are cross-specific antibody molecules with binding specificity for both AREG and HBEGF. The antibody molecules may be used in methods of treatment of cancer and diseases associated with angiogenesis.
摘要翻译: 描述了对AREG和HBEGF具有结合特异性的交叉特异性抗体分子。 抗体分子可用于治疗癌症和与血管发生相关的疾病的方法。
-
公开(公告)号:US20100104554A1
公开(公告)日:2010-04-29
申请号:US12281356
申请日:2007-03-02
申请人: Christopher Scott , Roberta Burden , Jim Johnston , Mark McCurley , Philip Snoddy , Richard Buick
发明人: Christopher Scott , Roberta Burden , Jim Johnston , Mark McCurley , Philip Snoddy , Richard Buick
IPC分类号: A61K39/395 , A61K38/48 , C12P21/06 , C12N9/64 , A61K38/00 , A61K31/7088
CPC分类号: A61K38/4873
摘要: A method of inhibiting activity of a cathepsin L-like protease in cells or tissue and the use of the method in the treatment of disease such as cancer and inflammatory diseases is described. The method comprises administration of a cathepsin propeptide or a nucleic acid encoding a cathepsin propeptide. In particular embodiments, the propeptide is a Cathepsin S propeptide. Further, the use of propeptides having an Fc portion is described.
摘要翻译: 描述了抑制组织蛋白酶L样蛋白酶在细胞或组织中的活性的方法以及该方法在治疗疾病如癌症和炎性疾病中的用途。 该方法包括给予组织蛋白酶前肽或编码组织蛋白酶前肽的核酸。 在具体实施方案中,前肽是组织蛋白酶S前肽。 此外,描述了使用具有Fc部分的前肽。
-
公开(公告)号:US20100086551A1
公开(公告)日:2010-04-08
申请号:US12444928
申请日:2007-10-12
IPC分类号: A61K39/395 , C12N5/02 , A61K31/7088 , C07K16/00 , G01N33/53
CPC分类号: A61K31/7088 , A61K39/395 , A61K45/06 , A61K48/00 , A61K2039/505 , C07K16/18 , C07K16/28 , C07K16/40 , C07K2317/73 , C07K2317/76 , C12N9/6472 , C12Q1/37 , G01N33/573 , G01N33/57496 , G01N2333/96466 , A61K2300/00
摘要: A method of inhibiting angiogenesis in a group of cells, a tissue or an organ includes administering an antibody molecule or nucleic acid encoding an antibody molecule to the cells, tissue or organ, wherein the antibody molecule specifically binds cathepsin S, but does not inhibit proteolytic activity of cathepsin S.
摘要翻译: 一种抑制一组细胞,组织或器官中的血管发生的方法包括将抗体分子或编码抗体分子的核酸施用于细胞,组织或器官,其中抗体分子特异性结合组织蛋白酶S,但不抑制蛋白水解 组织蛋白酶S的活性
-
公开(公告)号:US08475803B2
公开(公告)日:2013-07-02
申请号:US11919530
申请日:2006-05-02
CPC分类号: G01N33/5695
摘要: The invention relates to the identification of mycobacterial antigens which are highly immunogenic and which may be used in assays and methods for the diagnosis of tuberculosis and the discrimination between infected animals and animals previously exposed to vaccines.
-
公开(公告)号:US07939642B2
公开(公告)日:2011-05-10
申请号:US11918102
申请日:2006-04-10
申请人: Christopher Scott , Roberta Burden , Shane Olwill , Brian Walker , Jim Johnston
发明人: Christopher Scott , Roberta Burden , Shane Olwill , Brian Walker , Jim Johnston
IPC分类号: C12P21/08
CPC分类号: C07K16/40 , A61K2039/505 , C07K2317/56 , C07K2317/76 , C07K2317/92
摘要: Described are specific binding members e.g. antibodies which may be used in the treatment of diseases associated with cathepsin S activity. The specific binding members binds cathepsin S and inhibits its proteolytic activity. The binding members may be used in the treatment of diseases such as cancer, inflammatory diseases, neurodegenerative disorders, autoimmune disorders, and other diseases associated with excessive, deregulated or inappropriate angiogenesis.
摘要翻译: 描述的是具体的结合成员,例如 可用于治疗与组织蛋白酶S活性相关的疾病的抗体。 特异性结合成员结合组织蛋白酶S并抑制其蛋白水解活性。 结合成员可用于治疗诸如癌症,炎性疾病,神经变性疾病,自身免疫性疾病以及与过度,失调或不合适的血管生成相关的其它疾病的疾病。
-
公开(公告)号:US20110020404A1
公开(公告)日:2011-01-27
申请号:US12673798
申请日:2008-08-18
申请人: Shane A. Olwill , James A. Johnston , Hang Fai Kwok , Clare Whelan , John Clarke
发明人: Shane A. Olwill , James A. Johnston , Hang Fai Kwok , Clare Whelan , John Clarke
CPC分类号: G01N33/5695 , A61K39/04
摘要: The invention relates to methods for diagnosis of tuberculosis in an animal, the methods comprising determining the presence or absence of, or an immune response to a group of antigens comprising (i) the group consisting of Rv3616 antigen, MPB70 antigen, MPB83 antigen, and ESAT 6 antigen; or (ii) at least seven of the antigens of the group consisting of Rv3616 antigen, MPB70 antigen, MPB83 antigen, ESAT 6 antigen, CFP10 antigen, α crystalline 2 antigen, PE35 antigen, and PPE68 antigen. Also provided is a method for the diagnosis of the presence of tuberculosis in a reservoir animal e.g. a badger, said method comprising determining the presence or absence of, or an immune response to Rv3616 antigen, MPB70 antigen, and MPB83 antigen. Kits for carrying out the methods are also provided.
摘要翻译: 本发明涉及用于诊断动物结核病的方法,所述方法包括确定对抗原组的存在或不存在或免疫应答,所述抗原组包含(i)由Rv3616抗原,MPB70抗原,MPB83抗原和 ESAT 6抗原; 或(ii)由Rv3616抗原,MPB70抗原,MPB83抗原,ESAT6抗原,CFP10抗原,α结晶2抗原,PE35抗原和PPE68抗原组成的组中的至少7种抗原。 还提供了用于诊断储存动物中结核病存在的方法,例如, 所述方法包括确定Rv3616抗原,MPB70抗原和MPB83抗原的存在或不存在或免疫应答。 还提供了实施方法的工具包。
-
公开(公告)号:US20090317405A2
公开(公告)日:2009-12-24
申请号:US11918102
申请日:2006-04-10
申请人: Christopher Scott , Roberta Burden , Shane Olwill , Brian Walker , Jim Johnston
发明人: Christopher Scott , Roberta Burden , Shane Olwill , Brian Walker , Jim Johnston
IPC分类号: A61K39/395 , A61K31/7052 , C07K16/00 , C07H21/00 , C12P21/00 , A61P35/00 , A61P29/00 , A61P27/02 , A61K48/00
CPC分类号: C07K16/40 , A61K2039/505 , C07K2317/56 , C07K2317/76 , C07K2317/92
摘要: Described are specific binding members e.g. antibodies which may be used in the treatment of diseases associated with cathepsin S activity. The specific binding members bind cathepsin S and inhibit its proteolytic activity. The binding members may be used in the treatment of diseases such as cancer, inflammatory diseases, neurodegenerative disorders, autoimmune disorders, and other diseases associated with excessive, deregulated or inappropriate angiogenesis.
摘要翻译: 描述的是具体的结合成员,例如 可用于治疗与组织蛋白酶S活性相关的疾病的抗体。 特异性结合成员结合组织蛋白酶S并抑制其蛋白水解活性。 结合成员可用于治疗诸如癌症,炎性疾病,神经变性疾病,自身免疫性疾病以及与过度,失调或不合适的血管生成相关的其它疾病的疾病。
-
公开(公告)号:US20090053258A1
公开(公告)日:2009-02-26
申请号:US11919530
申请日:2006-05-02
IPC分类号: A61K39/00 , C12Q1/02 , G01N33/569 , A61P31/00 , C12Q1/68
CPC分类号: G01N33/5695
摘要: The invention relates to the identification of mycobacterial antigens which are highly immunogenic and which may be used in assays and methods for the diagnosis of tuberculosis and the discrimination between infected animals and animals previously exposed to vaccines.
摘要翻译: 本发明涉及高度免疫原性的分枝杆菌抗原的鉴定,其可用于诊断结核病的测定和方法以及先前暴露于疫苗的感染动物和动物之间的区别。
-
公开(公告)号:US20070110761A1
公开(公告)日:2007-05-17
申请号:US10540415
申请日:2003-12-29
申请人: Christopher Scott
发明人: Christopher Scott
CPC分类号: C12N15/70 , C07K2319/20 , C07K2319/21 , C07K2319/23 , C12N9/104 , C12N9/52
摘要: Described is a novel purification tag, SNUT, based on the gene product of a sortase gene, in particular the srtA gene of Staphylococcus aureus and uses thereof. Also provided are expression constructs comprising DNA enoding the tag for the production of recombinant polypeptides. The tag can be used in methods of purifying soluble domains of a number of proteins previously not able to be isolated efficiently and methods of inducing and/or enhancing an immune response to an antigen of interest.
摘要翻译: 描述了基于分选酶基因的基因产物,特别是金黄色葡萄球菌的srtA基因的新型纯化标签SNUT及其用途。 还提供了包含编码用于产生重组多肽的标签的DNA的表达构建体。 该标签可用于纯化先前不能有效分离的许多蛋白质的可溶性结构域的方法,以及诱导和/或增强对感兴趣的抗原的免疫应答的方法。
-
-
-
-
-
-
-
-
-